مورد إلكتروني
The impact of pharmacist-led strategies implemented to reduce errors related to cancer therapies: a systematic review.
| العنوان: | The impact of pharmacist-led strategies implemented to reduce errors related to cancer therapies: a systematic review. |
|---|---|
| بيانات النشر: | Wiley-Blackwell Australia 2021-01-13 2021-01-13 |
| تفاصيل مُضافة: | Vasileff H.M. Page A.T. Percival M.A. Rowan G.D. O'Connor S.R. Bortz H.D. Tey A.Y. Siderov J. Coutsouvelis J. |
| نوع الوثيقة: | Electronic Resource |
| مستخلص: | Background: Patients with cancer are managed across the whole healthcare spectrum. This complex system of interdependencies has high potential for errors to occur. This is a focus area for pharmacists, who possess the skillset to optimise cancer care across the health care system, identifying errors and other medication-related problems (MRP). Aim(s): The aim of this study was to identify and describe the impact of the pharmacist's contribution in reducing cancer therapy-related errors. Method(s): A search of English-language publications in Embase, Medline and CINAHL was conducted. Databases were searched from 1 January 2010 until 29 September 2020 to identify all quantitative studies of a descriptive, observational or experimental design. Articles describing pharmacist-led interventions in adults receiving one or more cancer therapies including oral chemotherapy, intravenous chemotherapy or immunotherapy compared to no intervention, usual care or a service delivered by another healthcare professional were included. Researchers screened articles to identify eligible studies, and then data were extracted using a standardised data collection sheet. Quality assessment was undertaken using the modified Cochrane and the Newcastle Ottawa risk of bias tools. Data were reported as number or percentage. Result(s): Of 2292 papers identified, nine studies were eligible for inclusion in this review. Pharmacist interventions consistently showed an increased identification of medication errors and medication-related problems. Pharmacist contributions in many of the included studies comprised medication reviews and monitoring, laboratory monitoring, adverse drug reaction and drug-drug interaction management, adherence monitoring and medication counselling. All studies showed pharmacist intervention in cancer care resulted in fewer errors compared to control arms. Error minimisation was described for parenteral and oral cancer therapies and also for supportive medications such as |
| مصطلحات الفهرس: | male, malignant neoplasm/dt [Drug Therapy], medication compliance, medication error, medication therapy management, metastasis/dt [Drug Therapy], multiple cycle treatment, multiple myeloma/dt [Drug Therapy], pneumocystosis/dt [Drug Therapy], pneumocystosis/pc [Prevention], potentially inappropriate medication, quality control, randomized controlled trial (topic), review, solid malignant neoplasm/dt [Drug Therapy], stomach cancer/dt [Drug Therapy], systematic review, teleconsultation, thrombosis prevention, venous thromboembolism/dt [Drug Therapy], venous thromboembolism/pc [Prevention], abiraterone/dt [Drug Therapy], abiraterone/pv [Special Situation for Pharmacovigilance], antiemetic agent/ae [Adverse Drug Reaction], antiemetic agent/dt [Drug Therapy], antifungal agent/dt [Drug Therapy], antiinfective agent, antineoplastic agent/ae [Adverse Drug Reaction], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/iv [Intravenous Drug Administration], antineoplastic agent/po [Oral Drug Administration], antineoplastic agent/pa [Parenteral Drug Administration], antineoplastic agent/pv [Special Situation for Pharmacovigilance], antithrombocytic agent/dt [Drug Therapy], bicalutamide/dt [Drug Therapy], bicalutamide/pv [Special Situation for Pharmacovigilance], bisphosphonic acid derivative, calcium, corticosteroid, dexamethasone/pv [Special Situation for Pharmacovigilance], enzalutamide/dt [Drug Therapy], enzalutamide/pv [Special Situation for Pharmacovigilance], erlotinib/pv [Special Situation for Pharmacovigilance], gefitinib/pv [Special Situation for Pharmacovigilance], gimeracil plus oteracil potassium plus tegafur/dt [Drug Therapy], gimeracil plus oteracil potassium plus tegafur/pv [Special Situation for Pharmacovigilance], influenza vaccine, ondansetron/pv [Special Situation for Pharmacovigilance], vitamin D, drug choice, adjuvant chemotherapy, adjuvant therapy, adult, adverse drug reaction/si [Side Effect], aged, antibiotic prophylaxis, cancer chemotherapy, cancer immunotherapy, cancer palliative therapy, castration resistant prostate cancer/dt [Drug Therapy], chemotherapy induced nausea and vomiting/dt [Drug Therapy], chemotherapy induced nausea and vomiting/si [Side Effect], clinical pharmacy, controlled study, corticosteroid therapy, drug interaction, female, follow up, health care planning, human, influenza vaccination, Review |
| URL: | Journal of Pharmacy Practice and Research Click here for full text options LibKey Link |
| الإتاحة: | Open access content. Open access content Copyright 2021 Elsevier B.V., All rights reserved. |
| أرقام أخرى: | AUSHL oai:repository.monashhealth.org:1/28684 Journal of Pharmacy Practice and Research. 50 (6) (pp 466-480), 2020. Date of Publication: December 2020. 1445-937X https://repository.monashhealth.org/monashhealthjspui/handle/1/28684Test Monash Health Pharmacy Percival, Mia A.; ORCID: http://orcid.org/0000-0003-4385-8544Test O'Connor, Shaun R.; ORCID: http://orcid.org/0000-0002-4971-1693Test 2007635777 (Coutsouvelis, Bortz, Page, Percival) Pharmacy Department, The Alfred, Melbourne, VIC, Australia (Coutsouvelis, Page) Centre for Medication Use and Safety, Monash University, Parkville, VIC, Australia (Siderov) Pharmacy Department, Austin Health, Heidelberg, VIC, Australia (Tey) Pharmacy Department, Monash Health, Clayton, VIC, Australia (O'Connor) Haematology Department, St Vincent's Hospital, Melbourne, VIC, Australia (O'Connor) Health & Wellbeing Division, Department of Health & Human Services, Melbourne, VIC, Australia (Rowan) Pharmacy Department, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (Vasileff) SA Pharmacy, Women's and Children's Hospital, North Adelaide, SA, Australia Coutsouvelis J.; j.coutsouvelis@alfred.org.au (Coutsouvelis, Bortz, Page, Percival) Pharmacy Department, The Alfred, Melbourne, VIC, Australia (Coutsouvelis, Page) Centre for Medication Use and Safety, Monash University, Parkville, VIC, Australia (Siderov) Pharmacy Department, Austin Health, Heidelberg, VIC, Australia (O'Connor) Haematology Department, St Vincent's Hospital, Melbourne, VIC, Australia (O'Connor) Health & Wellbeing Division, Department of Health & Human Services, Melbourne, VIC, Australia (Rowan) Pharmacy Department, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (Vasileff) SA Pharmacy, Women's and Children's Hospital, North Adelaide, SA, Australia (Tey) Pharmacy Department, Monash Health, Clayton, VIC, Australia 1305137541 |
| المصدر المساهم: | MONASH HEALTH LIBRS From OAIster®, provided by the OCLC Cooperative. |
| رقم الانضمام: | edsoai.on1305137541 |
| قاعدة البيانات: | OAIster |
| الوصف غير متاح. |